|
Sub-group variable
|
Sub-group category (L = Low or H = High)
|
N per sub group
|
Intervention arm
|
Standard care arm
|
Intervention- Control (SE)*
|
Difference (H-L) (95% C.I.)
|
P interaction
|
|---|
|
HbA1c % (mmol/mol)
|
7.5 – 7.9 (58-63)
|
85
|
80.4 (24.5)
|
62.6 (34.2)
|
17.7 (6.4)
| | |
| |
8.0 - 12.4 (64-112)
|
108
|
74.8 (27.7)
|
72.8 (27.8)
|
2.0 (5.3)
|
-15.8 (-32.9, 1.2)
|
0.07
|
|
Age (years)
|
37 – 64
|
94
|
75.0 (25.61)
|
72.3 (27.3)
|
2.7 (5.6)
| | |
| |
65 and over
|
100
|
80.0 (27.1)
|
66.4 (33.2)
|
13.5 (6.0)
|
10.8 (-5.4, 27.2)
|
0.19
|
|
Total number of medications
|
0 – 5
|
89
|
80.2 (23.3)
|
73.0 (27.0)
|
7.2 (5.3)
| | |
| |
6 and over
|
105
|
75.1 (28.5)
|
65 .2 (33.7)
|
10.0 (6.1)
|
2.8 (-13.5, 19.1)
|
0.74
|
|
Self reported adherence at baseline
|
0-23
|
102
|
75.0 (26.4)
|
70.9 (27.2)
|
4.1 (5.5)
| | |
| |
24 or 25
|
70
|
85.9 (21.3)
|
68.0 (33.9)
|
17.9 (6.8)
|
13.8 (-3.2, 30.0)
|
0.11
|
|
Prior randomisation to medication monitoring device
|
No
|
102
|
76.6 (28.7)
|
71.0 (29.3)
|
5.6 (5.8)
| | |
| |
Yes
|
92
|
78.2 (23.7)
|
66.65 (32.6)
|
11.6 (5.9)
|
6.0 (-10.5, 22.7)
|
0.48
|
|
Gender
|
Male
|
127
|
77.0 (28.3)
|
66.4 (31.5)
|
10.6 (5.3)
| | |
| |
Female
|
67
|
78.0 (22.9)
|
74.8 (28.8)
|
3.3 (6.4)
|
-7.3 (-24.3, 9.6)
|
0.39
|
- Effect estimates, confidence intervals and p-values from non-parametric bootstrap percentile method (50,000 replications).
- * Estimated intervention effects are positive within each subgroup.
